Lecture 2 Campylobateria

Embed Size (px)

DESCRIPTION

food microbiology

Citation preview

  • www.helsinki.fi/yliopisto www.helsinki.fi/yliopisto

    Campylobacter

    Alejandra Culebro

    Department of Food Hygiene and Environmental Health

    Faculty of Veterinary Medicine

  • www.helsinki.fi/yliopisto

    Campylobacteriosis

    The genus Campylobacter

    History

    Taxonomy

    Detection and isolation methods

    Typing methods

    Emerging campylobacters

    Overview

  • www.helsinki.fi/yliopisto 30.10.2013 3 Source: National Institute for Health and Welfare 2011

    0

    10

    20

    30

    40

    50

    60

    70

    80

    90

    2007 2008 2009 2010 2011

    Co

    nfi

    rmed

    cases p

    er

    100 0

    00 p

    op

    ula

    tio

    n

    Year

    Average of EU member states except for Latvia, Portugal,Romania, and Slovenia

    Finland

    Source: EFSA 2009; EFSA 2010; EFSA 2011; EFSA and ECDC 2012; EFSA and ECDC 2013

    Salmonella Campylobacter

  • www.helsinki.fi/yliopisto

    Campylobacter

    Source: THL

  • www.helsinki.fi/yliopisto Source: EFSA 2010; EFSA 2011

  • www.helsinki.fi/yliopisto 6

    0

    20

    40

    60

    80

    100

    120

    140

    160

    180

    200

    Fin EU US CR NewZealand

    UK

  • www.helsinki.fi/yliopisto

    500-800 cells

    3.2 days

    Self-limiting

    Relapse 5-10%

    Symptoms

    Source: Black and others 1988; Feodoroff and others 2011; Pacanowski 2008; Skirrow 1977

    Yet - Ingested dose

    - Strains virulence - Acquired immunity

    - Health status

  • www.helsinki.fi/yliopisto

    Treatment and prevention

    Treatment:

    No treated

    BUT:

    Erythromycin (Acheson and Allos 2001; Taylor and Tracz 2005)

    Macrolides, fluoroquinolones, and tetracyclines (Engberg and others 2001; Rapp 2007)

    Antibiotic resistance (de Jong and others 2012)

    Prevention:

    Vaccine (?)

    Control

  • www.helsinki.fi/yliopisto

    Reservoirs and risk factors

  • www.helsinki.fi/yliopisto

    So, what

    about?

    21.70%

    75.8%, 10-10 000

    CFU/g

  • www.helsinki.fi/yliopisto

    - 28.11.2007-31.12.2007

    - Cross-connection between

    sewage- and drinking-water

    pipelines

    - 9500 residents: 50% ill

    - 2052 healthcare visits

    - Cost: EUR 354,496: EUR77/

    patient

  • www.helsinki.fi/yliopisto

    - Regurgitation

    - Nausea

    - Indigestion

    - Heartburn

  • www.helsinki.fi/yliopisto

    Sequels

    Characteristics of post-campylobacteriosis-diseases.

    Adapted from: Smith 2002; Kozminski 2008.

  • www.helsinki.fi/yliopisto

    1886: Theodor Escherich: neonates

    1913: McFadyean and Stockman: ovine foetuses

    1963: Vibrio fetus and Vibrio bubulus Vibrio

    1970s:

    Filtration technique

    Selective media

    History of Campylobacter

    Source: Charlier and others 1974; Ebruyned and others 2008; Kist 1986; McFadyean and Stockman 1913; Skirrow

    1977; Skirrow 2006; Vron and Chatelain 1973

  • www.helsinki.fi/yliopisto 15

    History of Campylobacter

    By Joana Revez

  • www.helsinki.fi/yliopisto

    Campylobacter

    Source: Kaur and others 2011

    Campylobacter coli, Gram-stain, 100X oil immersion

    objective

  • www.helsinki.fi/yliopisto

    Really? Another new

    Campylobacter species?

    Campylobacter iguaniorum (Maarten Gilbert, CDC)

    Campylobacter fetus subsp. testudinum (Collette

    Fitzgerald, CDC)

    Campylobacter stanleyi (Lawson, UK)

    New C. laninae-like Campylobacter species (Miller, USDA)

  • www.helsinki.fi/yliopisto

    Challenges:

    Low levels of contamination (Oyarzabal and others 2007)

    VBNC (Chaisowwong and others 2012).

    No Gold standard

    Isolation and detection of

    Campylobacter sp.

  • www.helsinki.fi/yliopisto

    19

    Isolation

    Man, S. M. (2011) The clinical importance of emerging Campylobacter species

    Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2011.191. EFSA 2010; EFSA ; ECDC 2013; ISO 2006; ISO 2006

    The ISO 10272-1:2006: Bolton for 4-6 h 37 C

    FDA : pre-enrichment 4 h at 37 C or 3 h at 30 C +

    2 h at 37 C. Enrichment 42 C for 20-44 h, and

    streaking of 24 h and 48 h

    The ISO 10272-1:2006: plating in mCCD agar and a 2nd

    medium of own choice at 41.5 C for 40-48.

    Microaerobic

  • www.helsinki.fi/yliopisto

  • www.helsinki.fi/yliopisto

    Isolation methods drawbacks

    Method of choice impacts the recovery of Campylobacter from food samples (Edson and others 2009).

    Underestimation of prevalence (Oyarzabal and others 2013).

    Cumulative 9-year false-negative rates (Edson and others 2009):

    C. jejuni : 13.6%

    C. coli is 24%

    E. coli O157:H7: 7.8%

    Salmonella spp. :5.9%

    L. monocytogenes : 7.2

  • www.helsinki.fi/yliopisto

    Gram-negative Nonsporeformers small spiral,

    curved, or S-

    shaped rods (0.20.8 m wide and 0.55.0 m long)

    Microaerophilic

  • www.helsinki.fi/yliopisto

    Common identification methods in

    clinical samples Hip (-) Hip (+)

  • www.helsinki.fi/yliopisto 24

    Who said there is only C. jejuni?

    Fitzgerald, CHRO2013

    CDC, USA

    Presumptive

    Campylobacter strains

    (864), primarily hippurate

    negative strains (2000-

    2012)

    48% No-C. jejuni/C. coli

  • www.helsinki.fi/yliopisto

    Typing methods

    Adapted from: Moore and others 2006

  • www.helsinki.fi/yliopisto

    Typing methods

  • www.helsinki.fi/yliopisto

    Typing methods

    Phenotype

    Penner: soluble

    heat-stable

    Lior: heat labile

    antigens

    Grow at 28 C

    Hippurate

    DNA hydrolysis

    H2S production

    Resistotyping tests

  • www.helsinki.fi/yliopisto

    60 isolates

    Serotyping

    Penner and Hennessy: 89%, 10 serotypes

    Lior and others: 45%, 8 serotypes

    Biotyping

    Skirrow and Benjamin: Cj: 2 biotypes

    Roop and others: Cj: 2 biovars, Cc: 3

    Lior: Cj: 2 biotypes, Cc: 2

    Preston scheme: Cj: 7 biotypes, Cc: 18

    Phage typing Preston: 3 phage groups

    Khakhria and Lior: 3 phage groups

  • www.helsinki.fi/yliopisto

    Typing methods

    Genotype

    MLST PFGE fla

  • www.helsinki.fi/yliopisto

    70 C. coli: Humans (n=20) and retail meats (n=50)

    61 PFGE profiles with SmaI and KpnI

    MLST: 37 sequence types

  • www.helsinki.fi/yliopisto

    MLST

    Source: Sheppard and others 2013

  • www.helsinki.fi/yliopisto

    Outbreak: Salinas, Kansas

  • www.helsinki.fi/yliopisto

    Outbreak: Walkerton, ON

    1346-2300 13

    E.coli O157: H7

    >30 Source: Barton and others 2007; Clark and others 2003

  • www.helsinki.fi/yliopisto

    Virulence factors

    fla

    cdtB

    LOS

  • www.helsinki.fi/yliopisto

    WGS

  • www.helsinki.fi/yliopisto

    Are non-jejuni/coli emerging

    pathogens?

    36

    Allarmists Nonbelievers

    YES NO

  • www.helsinki.fi/yliopisto

    It is isolated more frequently:

    1. It is the most frequent

    enteric pathogen

    2. The methods dont allow the correct

    isolation/identification

    of other cryptic -proteobacteria

    Why we speak only about C.

    jejuni?

    37

    Underestimation

    Allarmists

    Nonbelievers

  • www.helsinki.fi/yliopisto

    Unknown etiology:

    49% of the 1.7 million cases of foodborne diseases reported between 1996 and 2000 in England and Wales

    (UK)

    68% of 41,000 hospital diagnoses of gastroenteritis reported annually in Australia.

    Campylobacter spp. other than C. jejuni/C. coli frequently be recovered from a substantial portion of

    undiagnosed gastroenteritis cases.

    38

    Undiagnosed human

    campylobacteriosis

    Man, S. M. (2011) The clinical importance of emerging Campylobacter species

    Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2011.191

  • www.helsinki.fi/yliopisto

    Human diarrhoeic samples

    C. jejuni

    40%

    Other Campylobacter spp.

    50%

    C. coli

    3% C. fetus

    3%

    A. cryaerophilus

    1%

    A. butzleri

    5%

    39

    Who said there is only C. jejuni?

    Oleastro, CHRO2013

    Portugal

    (from September to

    November 2012)

    From 99/299 (33.2%)

    stool samples of patients

    with diarrhoea positive for

    -proteobacteria

    60% No-C. jejuni/C. coli

    Higher in paediatric age

  • www.helsinki.fi/yliopisto 40

    Who said there is only C. jejuni?

    Bullman, 2011

    Cork, Ireland

    7194 patient faecal

    samples submitted to the

    Microbiology

    Laboratory. January

    2009 and December

    2009.

    349 (~5%) were

    determined to be

    Campylobacter

    genus-positive 29% No-C. jejuni/C. coli

  • www.helsinki.fi/yliopisto www.helsinki.fi/yliopisto

    Thank you

    For the list of references please contact me at: [email protected]